---
title: "LIPTON KAREN SHOOS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/65423bbe-004e-54b6-91a7-e142413225ff
json: https://whiteintel.dev/api/public/dossier/65423bbe-004e-54b6-91a7-e142413225ff
identifier: sec:0001255681
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LIPTON KAREN SHOOS

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001255681`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/65423bbe-004e-54b6-91a7-e142413225ff  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/65423bbe-004e-54b6-91a7-e142413225ff  

## Ownership & control

### Holdings / subsidiaries

- **AVANT IMMUNOTHERAPEUTICS INC** (director) — https://whiteintel.dev/entity/bdbef176-609b-5408-8bcb-5a44de87d983

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LIPTON KAREN SHOOS**. Human view: https://whiteintel.dev/entity/65423bbe-004e-54b6-91a7-e142413225ff · Structured JSON: https://whiteintel.dev/api/public/dossier/65423bbe-004e-54b6-91a7-e142413225ff._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._